KG8-29104-21026
2 vaccinations
2 coded responses
10 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 201 / VA
- Registered
- 2021-02-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-12
Dose 1 — Pfizer-BioNTech
-
2021-02-13
Registered in v-safe
- 2021-02-13
- 2021-02-17
- 2021-02-26
-
2021-03-01
Dose 2 — Pfizer-BioNTech
-
2021-03-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-03-06
- 2021-03-15
- 2021-04-05
-
2021-04-12
Survey response — day 42, dose 2MedDRA: Placental calcification, Pregnancy — Feeling: GoodFree text: Calcified placenta at 36 weeks gestation.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-31
Survey response — 3 months, dose 2MedDRA: Pregnancy, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Early placental calcifications noticed on ultrasound at 36 weeks gestation. Healthy pregnancy otherwise, No other risk factors (No history of GDM, HTN, etc). · Healthcare visit (other): Maternal fetal medicine weekly NSTs for baby. Delivery at 38 weeks.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-31
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-03
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-12 | Pfizer-BioNTech | |
| 2 | 2021-03-01 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 7 — day 42, dose 2
Symptoms: Calcified placenta at 36 weeks gestation.
Release 8 — 3 months, dose 2
Symptoms: Early placental calcifications noticed on ultrasound at 36 weeks gestation. Healthy pregnancy otherwise, No other risk factors (No history of GDM, HTN, etc).
Healthcare visit (other): Maternal fetal medicine weekly NSTs for baby. Delivery at 38 weeks.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Placental calcification | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release